KURA ONCOLOGY INC. - COMMON STOCK
7.3200
10-一月-25 16:45:00
15 分钟延时
股票
-0.4600
-5.91%
今日范围
7.1750 - 7.7286
ISIN
N/A
来源
NASDAQ
-
23 10月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology
30 9月 2024 18:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology Appoints Michael Vasconcelles, M.D., to Board of Directors
17 9月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Cantor Global Healthcare Conference
10 9月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology Reports Second Quarter 2024 Financial Results
08 8月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
08 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology to Report Second Quarter 2024 Financial Results
01 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 7月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology Reports Preclinical Data Supporting Potential for Menin Inhibitor in Diabetes
24 6月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 6月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Jefferies Global Healthcare Conference
29 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
14 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
08 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology Reports First Quarter 2024 Financial Results
02 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology to Report First Quarter 2024 Financial Results
25 4月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
22 4月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Stifel Targeted Oncology Forum
10 4月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 4月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
NetDania - New 12 months High: KURA ONCOLOGY INC. - COMMON STOCK
11 3月 2024 09:53:56 条件 NetDania Notify